James W. Kupiec

Clinical trial of an inhibitor of RAGE-Aβ interactions in Alzheimer disease

Douglas Galasko, J. Simon Bell, Jessica Mancuso et al. · Neurology · 2014 · 181 citations · Full text

Medicine, Neurology, Pharmacology +17

Comparison of Amlodipine and Benazepril Monotherapy to Amlodipine Plus Benazepril In Patients with Systemic Hypertension: A Randomized, Double‐Blind, Placebo‐Controlled, Parallel‐Group Study

William H. Frishman, C. Venkata S. Ram, F. Gilbert McMahon et al. · The Journal of Clinical Pharmacology · 1995 · 92 citations

Medicine, Pharmacology, Pharmacotherapy +12

Safety and Pharmacology of a Single Intravenous Dose of Ponezumab in Subjects With Mild-to-Moderate Alzheimer Disease

Jaren W. Landen, Qinying Zhao, Sharon Cohen et al. · Clinical Neuropharmacology · 2013 · 86 citations

Medicine, Neurology, Pharmacology +17

First-In-Human safety and long-term exposure data for AAB-003 (PF-05236812) and biomarkers after intravenous infusions of escalating doses in patients with mild to moderate Alzheimer’s disease

Marielle Delnomdedieu, Sridhar Duvvuri, David Jianjun Li et al. · Alzheimer s Research & Therapy · 2016 · 57 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Safety and Pharmacology of Ponezumab (PF-04360365) After a Single 10-Minute Intravenous Infusion in Subjects With Mild to Moderate Alzheimer Disease

Aaron H. Burstein, Qinying Zhao, Joel Ross et al. · Clinical Neuropharmacology · 2013 · 51 citations

Medicine, Pharmacokinetics, Pharmacology +17